Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 228

1.

Intravesical irrigation might prevent bladder recurrence in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.

Yamamoto S, Sakamoto S, Imamura Y, Sazuka T, Nakamura K, Inoue T, Chiba K, Miyazaki K, Inoue A, Nagata M, Ichikawa T.

Int J Urol. 2019 May 12. doi: 10.1111/iju.14014. [Epub ahead of print]

PMID:
31081198
2.

Higher Serum Testosterone Levels Associated with Favorable Prognosis in Enzalutamide- and Abiraterone-Treated Castration-Resistant Prostate Cancer.

Sakamoto S, Maimaiti M, Xu M, Kamada S, Yamada Y, Kitoh H, Matsumoto H, Takeuchi N, Higuchi K, Uchida HA, Komiya A, Nagata M, Nakatsu H, Matsuyama H, Akakura K, Ichikawa T.

J Clin Med. 2019 Apr 11;8(4). pii: E489. doi: 10.3390/jcm8040489.

3.

Role of pre-miR-532 (miR-532-5p and miR-532-3p) in regulation of gene expression and molecular pathogenesis in renal cell carcinoma.

Yamada Y, Arai T, Kato M, Kojima S, Sakamoto S, Komiya A, Naya Y, Ichikawa T, Seki N.

Am J Clin Exp Urol. 2019 Feb 18;7(1):11-30. eCollection 2019.

4.

Micro-ribonucleic acid expression signature of metastatic castration-resistant prostate cancer: Regulation of NCAPH by antitumor miR-199a/b-3p.

Arai T, Kojima S, Yamada Y, Sugawara S, Kato M, Yamazaki K, Naya Y, Ichikawa T, Seki N.

Int J Urol. 2019 Apr;26(4):506-520. doi: 10.1111/iju.13911. Epub 2019 Feb 28.

PMID:
30818424
5.

Usefulness of Renal Autotransplantation for Radiotherapy-induced Renovascular Hypertension.

Wakabayashi S, Takaoka H, Miyauchi H, Sazuka T, Saito Y, Sugimoto K, Funabashi N, Ichikawa T, Matsubara H, Kobayashi Y.

Intern Med. 2019 Feb 25. doi: 10.2169/internalmedicine.2001-18. [Epub ahead of print]

6.

Prospective clinical trial of 12-fraction carbon-ion radiotherapy for primary renal cell carcinoma.

Kasuya G, Tsuji H, Nomiya T, Makishima H, Haruyama Y, Kobashi G, Hayashi K, Ebner DK, Omatsu T, Kishimoto R, Yasuda S, Igarashi T, Oya M, Akakura K, Suzuki H, Ichikawa T, Shimazaki J, Kamada T; Working Group for Genitourinary Tumors.

Oncotarget. 2019 Jan 1;10(1):76-81. doi: 10.18632/oncotarget.26539. eCollection 2019 Jan 1.

7.

Guideline for cryopreservation of unfertilized eggs and ovarian tissues in Japan Society of Reproductive Medicine: Ethics Committee in Japan Society of Reproductive Medicine.

Harada T, Kuji N, Ishihara O, Ichikawa T, Irahara M, Katagiri Y, Saito H, Harada T, Wada-Hiraike O, Taniguchi F; Ethics Committee in Japan Society of Reproductive Medicine.

Reprod Med Biol. 2018 Oct 23;18(1):3-6. doi: 10.1002/rmb2.12236. eCollection 2019 Jan. No abstract available.

8.

Quality-of-life predictors for men undergoing infertility treatment in Japan.

Asazawa K, Jitsuzaki M, Mori A, Ichikawa T, Shinozaki K, Porter SE.

Jpn J Nurs Sci. 2018 Dec 7. doi: 10.1111/jjns.12248. [Epub ahead of print]

PMID:
30525294
9.

Pirin: a potential novel therapeutic target for castration-resistant prostate cancer regulated by miR-455-5p.

Arai T, Kojima S, Yamada Y, Sugawara S, Kato M, Yamazaki K, Naya Y, Ichikawa T, Seki N.

Mol Oncol. 2019 Feb;13(2):322-337. doi: 10.1002/1878-0261.12405. Epub 2018 Dec 21.

10.

Vasovasostomy and vasoepididymostomy: Review of the procedures, outcomes, and predictors of patency and pregnancy over the last decade.

Namekawa T, Imamoto T, Kato M, Komiya A, Ichikawa T.

Reprod Med Biol. 2018 May 22;17(4):343-355. doi: 10.1002/rmb2.12207. eCollection 2018 Oct. Review.

11.

Chronological changes in epidemiological characteristics of lower urinary tract urolithiasis in Japan.

Sakamoto S, Miyazawa K, Yasui T, Iguchi T, Fujita M, Nishimatsu H, Masaki T, Hasegawa T, Hibi H, Arakawa T, Ando R, Kato Y, Ishito N, Yamaguchi S, Takazawa R, Tsujihata M, Taguchi M, Akakura K, Hata A, Ichikawa T.

Int J Urol. 2019 Jan;26(1):96-101. doi: 10.1111/iju.13817. Epub 2018 Oct 11.

PMID:
30308705
12.

Contribution of Human Liver and Intestinal Carboxylesterases to the Hydrolysis of Selexipag In Vitro.

Imai S, Ichikawa T, Sugiyama C, Nonaka K, Yamada T.

J Pharm Sci. 2019 Feb;108(2):1027-1034. doi: 10.1016/j.xphs.2018.09.022. Epub 2018 Sep 26.

PMID:
30267780
13.

Molecular pathogenesis of renal cell carcinoma: Impact of the anti-tumor miR-29 family on gene regulation.

Yamada Y, Sugawara S, Arai T, Kojima S, Kato M, Okato A, Yamazaki K, Naya Y, Ichikawa T, Seki N.

Int J Urol. 2018 Nov;25(11):953-965. doi: 10.1111/iju.13783. Epub 2018 Aug 28.

PMID:
30153702
14.

Updated long-term outcomes after carbon-ion radiotherapy for primary renal cell carcinoma.

Kasuya G, Tsuji H, Nomiya T, Makishima H, Haruyama Y, Kobashi G, Ebner DK, Hayashi K, Omatsu T, Kishimoto R, Yasuda S, Igarashi T, Oya M, Akakura K, Suzuki H, Ichikawa T, Shimazaki J, Kamada T; Working Group for Genitourinary Tumors.

Cancer Sci. 2018 Sep;109(9):2873-2880. doi: 10.1111/cas.13727. Epub 2018 Sep 1.

15.

Regulation of antitumor miR-144-5p targets oncogenes: Direct regulation of syndecan-3 and its clinical significance.

Yamada Y, Arai T, Kojima S, Sugawara S, Kato M, Okato A, Yamazaki K, Naya Y, Ichikawa T, Seki N.

Cancer Sci. 2018 Sep;109(9):2919-2936. doi: 10.1111/cas.13722. Epub 2018 Jul 28.

16.

Assessing the Accuracy of Variant Detection in Cost-Effective Gene Panel Testing by Next-Generation Sequencing.

Fujiki R, Ikeda M, Yoshida A, Akiko M, Yao Y, Nishimura M, Matsushita K, Ichikawa T, Tanaka T, Morisaki H, Morisaki T, Ohara O.

J Mol Diagn. 2018 Sep;20(5):572-582. doi: 10.1016/j.jmoldx.2018.04.004. Epub 2018 Jun 25.

PMID:
29953964
17.

Anti-tumor roles of both strands of the miR-455 duplex: their targets SKA1 and SKA3 are involved in the pathogenesis of renal cell carcinoma.

Yamada Y, Arai T, Kojima S, Sugawara S, Kato M, Okato A, Yamazaki K, Naya Y, Ichikawa T, Seki N.

Oncotarget. 2018 Jun 1;9(42):26638-26658. doi: 10.18632/oncotarget.25410. eCollection 2018 Jun 1.

18.

Treatment strategy for metastatic prostate cancer with extremely high PSA level: reconsidering the value of vintage therapy.

Yamada Y, Sakamoto S, Amiya Y, Sasaki M, Shima T, Komiya A, Suzuki N, Akakura K, Ichikawa T, Nakatsu H.

Asian J Androl. 2018 Sep-Oct;20(5):432-437. doi: 10.4103/aja.aja_24_18.

19.

Dr. Coffey's visionary contributions to urological research in China and Japan.

Shimazaki J, Chung LW, Zhau HE, Ichikawa T.

Am J Clin Exp Urol. 2018 Apr 1;6(2):15-22. eCollection 2018. No abstract available.

20.

Contralateral adrenal width predicts the duration of prolonged post-surgical steroid replacement for subclinical Cushing syndrome.

Sugiura M, Imamura Y, Kawamura K, Yamamoto S, Sazuka T, Nakamura K, Sakamoto S, Nagano H, Koide H, Tanaka T, Imamoto T, Komiya A, Ichikawa T.

Int J Urol. 2018 Jun;25(6):583-588. doi: 10.1111/iju.13566. Epub 2018 Apr 12.

PMID:
29651813

Supplemental Content

Loading ...
Support Center